Data shows that CBSA seized more than $75M in cocaine at southern Ontario ports of entry. A trucker on trial for allegedly transporting roughly $2 million of cocaine across the Canada-U.S. border is claiming to have no knowledge of what was in the trailer, according...
Press Release The Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and...
Portland city officials are considering an ordinance that would direct police to deprioritize calls regarding psychedelic mushrooms. The ordinance, which was brought before the City Council’s Community and Public Safety Committee on Tuesday, would amend city code to...
Recent research published in the Journal of Psychopharmacology suggests that the use of psychedelic substances does not reliably alter authoritarian political attitudes. These findings contrast with prior reports indicating that psychedelics might make...
If in doubt launch awards …… Psychedelic Awards 2026 October 10, 2026 Location San Francisco CA US The inaugural Psychedelic Awards 2026, presented by Psychedelic Literacy in partnership with the California Institute of Integral Studies, will...
‘I don’t think we have a homeless problem — we have a drug problem here,’ says Steve Ricalis; public meeting taking place today at city hall to discuss changes to zoning bylaw Source:...
With the launch of the Chambers USA 2026 guide, we are proud to announce that Vicente LLP has earned its eighth consecutive Band 1 nationwide ranking in Cannabis Law and a Band 1 ranking in Psychedelics Law for the third year running since the category launched in...
Marijuana Moment Connecticut’s governor has signed a bill to expand a pilot program that’s meant to explore the therapeutic potential of psychedelics such as psilocybin and MDMA. The legislation sponsored by the Joint Committee on Public Health cleared the House of...
Psyence Labs Ltd. disclosed a 30.05% stake in PSYENCE BIOMEDICAL LTD.’s common shares. The stake stems from a share‑for‑share exchange completed on Feb. 25, 2026, and was reported in a Schedule 13D filed on Jun. 03, 2026. The exchange valued Psyence Labs’...
